As combination mTOR and MEK inhibition was so effective in inhibiting MPNST cell growth, we next asked whether treatment reversed the nuclear localization of MET leading to global downregulation of MAPK and AKT/mTOR signaling. This evidence concerns the gene MAP2K7 and malignant peripheral nerve sheath tumor.